Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W J Strachan

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Clinical Endocrinology|July 9, 2025
Ten Year Outcome of Anti-Thyroid Drug Treatment for First Episode Graves' Thyrotoxicosis: The Predictive Importance of TRAbNyo Nyo Z Tun, Nicola N Zammitt, Mark W J Strachan, et al.
Cardiovascular Diabetology|April 28, 2022
Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetesZhe Huang, Lucija Klaric, Justina Krasauskaite, et al.
European Journal of Preventive Cardiology|May 12, 2023
Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetesZhe Huang, Lucija Klaric, Justina Krasauskaite, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 8, 2023
Changes in continuous glucose monitoring metrics and predictors of improvement 12 months after conversion from Freestyle Libre to Freestyle Libre 2Roland H Stimson, Anna R Dover, Mark W J Strachan, et al.
Journal of Diabetes Science and Technology|October 26, 2020
HbA1c Is Disproportionately Higher in Women and Older People With Type 1 Diabetes Compared With Flash Glucose Monitoring Metrics of Glycemic ControlRoland H Stimson, Anna R Dover, Shareen Forbes, et al.
Diabetologia|December 21, 2021
Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes StudyAnniek J Sluiman, Stela McLachlan, Rachel B Forster, et al.
Clinical Endocrinology|January 27, 2005
Changing trends in incidence and mortality of thyroid cancer in ScotlandRebecca M Reynolds, Jennifer Weir, Diane L Stockton, et al.
Diabetes, Obesity & Metabolism|October 10, 2024
Change in glycated haemoglobin in adults with type 2 diabetes on basal-bolus insulin regimens following commencement of Freestyle Libre useAnna R Dover, Rohana J Wright, Shareen Forbes, et al.
Clinical Endocrinology|August 16, 2003
Clinical and radiological features of patients with macroprolactinaemiaMark W J Strachan, Wei Leng Teoh, Andrew C Don-Wauchope, et al.
Thyroid : Official Journal of the American Thyroid Association|June 9, 2016
Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease RelapseNyo Nyo Z Tun, Geoff Beckett, Nicola N Zammitt, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Clinical Endocrinology|July 9, 2025
Ten Year Outcome of Anti-Thyroid Drug Treatment for First Episode Graves' Thyrotoxicosis: The Predictive Importance of TRAbNyo Nyo Z Tun, Nicola N Zammitt, Mark W J Strachan, et al.
Cardiovascular Diabetology|April 28, 2022
Serum metabolomic profiles associated with subclinical and clinical cardiovascular phenotypes in people with type 2 diabetesZhe Huang, Lucija Klaric, Justina Krasauskaite, et al.
European Journal of Preventive Cardiology|May 12, 2023
Combining serum metabolomic profiles with traditional risk factors improves 10-year cardiovascular risk prediction in people with type 2 diabetesZhe Huang, Lucija Klaric, Justina Krasauskaite, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 8, 2023
Changes in continuous glucose monitoring metrics and predictors of improvement 12 months after conversion from Freestyle Libre to Freestyle Libre 2Roland H Stimson, Anna R Dover, Mark W J Strachan, et al.
Journal of Diabetes Science and Technology|October 26, 2020
HbA1c Is Disproportionately Higher in Women and Older People With Type 1 Diabetes Compared With Flash Glucose Monitoring Metrics of Glycemic ControlRoland H Stimson, Anna R Dover, Shareen Forbes, et al.
Diabetologia|December 21, 2021
Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes StudyAnniek J Sluiman, Stela McLachlan, Rachel B Forster, et al.
Clinical Endocrinology|January 27, 2005
Changing trends in incidence and mortality of thyroid cancer in ScotlandRebecca M Reynolds, Jennifer Weir, Diane L Stockton, et al.
Diabetes, Obesity & Metabolism|October 10, 2024
Change in glycated haemoglobin in adults with type 2 diabetes on basal-bolus insulin regimens following commencement of Freestyle Libre useAnna R Dover, Rohana J Wright, Shareen Forbes, et al.
Clinical Endocrinology|August 16, 2003
Clinical and radiological features of patients with macroprolactinaemiaMark W J Strachan, Wei Leng Teoh, Andrew C Don-Wauchope, et al.
Thyroid : Official Journal of the American Thyroid Association|June 9, 2016
Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease RelapseNyo Nyo Z Tun, Geoff Beckett, Nicola N Zammitt, et al.
Pageof 11